- US FDA accepted NDA filing for ensifentrine for maintenance treatment of COPD
- PDUFA Target Action Date of June 26, 2024
- Commercial launch preparations supported by strong balance sheet
- Conference call today at 9:00 a.m. EDT / 1:00 p.m. GMT
Conference Call and Webcast Information
Verona Pharma will host an investment community webcast and conference call at 9:00 a.m. EDT / 1:00 p.m. GMT on Thursday, November 2, 2023, to discuss the third quarter 2023 financial results and the corporate update.
To participate, please dial one of the following numbers and ask to be placed into the Verona Pharma third quarter earnings call:
- +1-833-816-1396 for callers in the United States
- +1-412-317-0489 for international callers
A live webcast will be available on the Events and Presentations link on the Investors page of the Company's website, www.veronapharma.com, and the audio replay will be available for 90 days. An electronic copy of the third quarter 2023 results press release will also be made available today on the Company’s website.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.